HOME >> BIOLOGY >> NEWS
Prozac exposure found to disrupt mussel reproduction

Researchers from the National Institute of Standards and Technology (NIST) and North Carolina State University (NCSW) have demonstrated that a commonly prescribed antidepressant can interfere with the reproductive cycle of freshwater mussels--at least in a controlled setting. The research, presented this week at the national meeting of the American Chemical Society*, was conducted to better understand the environmental impact of pharmaceuticals in waste water.

More and more studies are turning up evidence of common drugs and their breakdown products in the nation's waterways (see NIST Tech Beat, www.nist.gov/public_affairs/techbeat/tb2005_1222.htm#drugs), raising concerns about potential health impacts for both humans and animals from low-level but continuous exposure to the chemicals. NIST and NCSU researchers at the Hollings Marine Laboratory (Charleston, S.C.) examined the effect of fluoxetine, a selective serotonin reuptake inhibitor (SSRI) on a native freshwater mussel (Elliptio complanata). Fluoxetine, sold under the trade name ProzacTM, is one of the most heavily prescribed antidepressants in the United States. In humans, it acts to increase the levels of serotonin at nerve synapses, relieving depression and associated illnesses. But for a number of aquatic species, serotonin moderates the reproductive system--and has been used to artificially induce spawning in bivalves.

At laboratory test concentrations, they found, fluoxetine caused female mussels carrying larvae to release them prematurely, and often, before they were viable, disrupting their reproductive cycle. Approximately 70 percent of the almost 300 species of North American freshwater mussels are considered vulnerable to extinction or already extinct.

The finding also raises questions about the effect of fluoxetine on other aquatic species that share similar endocrine mecha
'"/>

Contact: Michael Baum
michael.baum@nist.gov
301-975-2763
National Institute of Standards and Technology (NIST)
15-Sep-2006


Page: 1 2

Related biology news :

1. Ingredient in Prozac increases risk of extinction for freshwater mussels
2. Prozacs target revealed
3. Prozac improves learning and memory in fatal brain disease
4. Reading ability protects brain from lead exposure
5. Prenatal alcohol exposure alters brain activity in the frontal-striatal areas
6. Early environmental exposure may accelerate age-related neurodegeneration
7. Lung and bladder cancer deaths continue decades after arsenic exposure
8. Pregnant moms exposure to flu vaccine kick-starts fetal immune system
9. Study confirms the risk of exposure to secondhand tobacco smoke outdoors
10. Prenatal nicotine exposure can lead to cardiac function reprogramming in adult offspring
11. Early exposure to indoor fungus molecules may protect infants against future allergies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/1/2020)... , ... July 01, 2020 , ... ... awareness and solutions for glioblastoma—the most common and aggressive adult brain cancer—announced today ... JD, PhD. Senior Fellows are charged with supporting the organization’s initiatives and overall ...
(Date:6/28/2020)... , ... June 25, 2020 , ... In an upcoming ... innovations in accelerated Point of Care Testing solutions (POCT). Check local listings for more ... collected at medical offices and are shipped to labs throughout the country. Results are ...
(Date:6/23/2020)... ... June 23, 2020 , ... ... monoclonal antibody development services, today announced that the company has received ISO9001:2015 ... the pharmaceutical, diagnostics, and research industries. The decision to pursue ISO9001 accreditation ...
Breaking Biology News(10 mins):
(Date:9/1/2020)... ... September 01, 2020 , ... ... and diagnostics companies, has announced the placement of Julianne Averill , CPA, ... for leading all financial operations and implementing key business strategies to accelerate Alveo’s ...
(Date:8/12/2020)... ... August 11, 2020 , ... ... making available for free its new white paper – Simulated Transport Methodologies. ... into today’s biologics licensing application (BLA). In response, Modality Solutions shares an ...
(Date:7/31/2020)... ... July 29, 2020 , ... R3 Stem Cell International ... only $3950. With 50 million stem cells total, patients may choose which extremities they ... works for arthritic joints (BMC Musculoskelet Disord. 2016). At R3 International, umbilical cord tissue ...
(Date:7/31/2020)... ... ... eSource has long been touted as the solution to high data management and monitoring ... did not take off as quickly as people initially expected, and where eSource is ... data electronically for clinical trials and then repurposing it for downstream analysis, at a ...
Breaking Biology Technology:
Cached News: